We identified a valid, innovative, and reliable six epigenetic-related gene prognostic models (CBX2, PPM1G, RAD54B, RUVBL1, SAP30, and TTK) to predict HCC patient outcomes. This evidence concerns the gene CBX2 and hepatocellular carcinoma.